Back to RCUS
Candriam S.C.A. RCUS Position History
Arcus Biosciences, Inc. • Healthcare
Quarters held
6
Latest value
$13.9M
Q3 2026
Peak value
$20.4M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $5.1M |
| Q4 2025 | $18.8M |
| Q4 2025 | $18.8M |
| Q1 2026 | $17.1M |
| Q2 2026 | $20.4M |
| Q3 2026 | $13.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $13.9M | 536.8K | — | — |
| Q2 2026 | $20.4M | 662.0K | — | — |
| Q1 2026 | $17.1M | 790.6K | — | — |
| Q4 2025 | $18.8M | 790.6K | — | — |
| Q4 2025 | $18.8M | 790.6K | — | — |
| Q3 2025 | $5.1M | 378.4K | — | — |
Other funds holding RCUS
$185.9M
$185.9M
$116.9M
$100.3M
$96.7M
$96.7M
$80.7M